Butterfly Network Appoints Steve Cashman as Chief Business Officer
Butterfly Network (NYSE: BFLY) has appointed Steve Cashman as Chief Business Officer, effective immediately. Cashman, a seasoned healthcare leader, joins the company following its successful launch of the third-generation Butterfly iQ3 and record revenue performance in H1 2024. He will oversee global sales, marketing, product, and corporate strategy as part of the Executive Management Team.
Cashman brings extensive health technology expertise and commercial leadership, having previously served as CEO of Caption Health and CCO at InTouch Health. His appointment follows Butterfly's announcement of its highest quarterly revenue in Q2, reaching $21.5 million, a 16% year-over-year growth. This achievement underscores the growing demand for Butterfly's innovative ultrasound technology and the effectiveness of its strategy.
Butterfly Network (NYSE: BFLY) ha nominato Steve Cashman come Chief Business Officer, con effetto immediato. Cashman, un leader esperto nel settore sanitario, entra a far parte dell'azienda dopo il lancio di successo della terza generazione del Butterfly iQ3 e delle prestazioni di fatturato record nel primo semestre del 2024. Si occuperà delle vendite globali, del marketing, del prodotto e della strategia aziendale come parte del Team di Direzione Esecutiva.
Cashman porta con sé una vasta esperienza nella tecnologia sanitaria e nella leadership commerciale, avendo precedentemente ricoperto il ruolo di CEO di Caption Health e di CCO in InTouch Health. La sua nomina segue l'annuncio di Butterfly sul suo fatturato trimestrale più alto nel secondo trimestre, raggiungendo 21,5 milioni di dollari, con una crescita del 16% rispetto all'anno precedente. Questo risultato sottolinea la crescente domanda per la tecnologia innovativa degli ultrasuoni di Butterfly e l'efficacia della sua strategia.
Butterfly Network (NYSE: BFLY) ha nombrado a Steve Cashman como Director Comercial, con efecto inmediato. Cashman, un líder experimentado en el sector de la salud, se une a la compañía tras el exitoso lanzamiento de la tercera generación del Butterfly iQ3 y un rendimiento récord en los ingresos durante el primer semestre de 2024. Supervisará las ventas globales, el marketing, el producto y la estrategia corporativa como parte del Equipo de Gestión Ejecutiva.
Cashman aporta una amplia experiencia en tecnología de salud y liderazgo comercial, habiendo sido anteriormente CEO de Caption Health y CCO de InTouch Health. Su nombramiento sigue al anuncio de Butterfly de su ingreso trimestral más alto en el segundo trimestre, alcanzando 21,5 millones de dólares, con un crecimiento del 16% en comparación con el año anterior. Este logro subraya la creciente demanda por la tecnología innovadora de ultrasonido de Butterfly y la efectividad de su estrategia.
버터플라이 네트워크 (NYSE: BFLY)는 스티브 캐쉬맨을 최고 사업 책임자로 즉시 임명했습니다. 의료 분야의 다년간 경력을 가진 캐쉬맨은 2024년 상반기 동안 기록적인 수익 성과와 함께 세 번째 세대 버터플라이 iQ3의 성공적인 출시 이후 회사에 합류합니다. 그는 글로벌 영업, 마케팅, 제품 및 기업 전략을 총괄할 예정이며, 집행 관리 팀의 일원으로 활동하게 됩니다.
캐쉬맨은 이전에 캡션 헬스 CEO와 인터치 헬스 CCO로 재직하며 헬스케어 기술 및 상업적 리더십에 대한 방대한 전문 지식을 가지고 있습니다. 그의 임명은 버터플라이가 2분기 가장 높은 분기 수익을 보고한 후 이루어졌으며, 총 2150만 달러에 도달하여 전년 대비 16% 성장을 기록했습니다. 이 성과는 버터플라이의 혁신적인 초음파 기술에 대한 수요 증가와 전략의 효과를 강조합니다.
Butterfly Network (NYSE: BFLY) a nommé Steve Cashman au poste de Chief Business Officer, avec effet immédiat. Cashman, un leader expérimenté dans le domaine de la santé, rejoint l'entreprise après le lancement réussi de la troisième génération du Butterfly iQ3 et des performances record en matière de revenus au premier semestre 2024. Il supervisera les ventes mondiales, le marketing, le produit et la stratégie d'entreprise en tant que membre de l'équipe de direction exécutive.
Cashman apporte une vaste expertise en technologie de la santé et en leadership commercial, ayant été précédemment CEO de Caption Health et CCO d'InTouch Health. Sa nomination fait suite à l'annonce par Butterfly de son chiffre d'affaires trimestriel le plus élevé au deuxième trimestre, atteignant 21,5 millions de dollars, soit une croissance de 16 % par rapport à l'année précédente. Cette réussite souligne la demande croissante pour la technologie ultrasonore innovante de Butterfly et l'efficacité de sa stratégie.
Butterfly Network (NYSE: BFLY) hat Steve Cashman zum Chief Business Officer ernannt, mit sofortiger Wirkung. Cashman, ein erfahrener Fachmann im Gesundheitswesen, kommt nach dem erfolgreichen Start des dritten Generation Butterfly iQ3 und rekordverdächtigen Einnahmen im ersten Halbjahr 2024 zum Unternehmen. Er wird die globalen Verkäufe, das Marketing, das Produkt und die Unternehmensstrategie als Teil des Führungsteams leiten.
Cashman bringt umfangreiche Expertise in Gesundheitstechnologien und kommerzieller Führung mit, da er zuvor als CEO von Caption Health und CCO bei InTouch Health tätig war. Seine Ernennung folgt der Ankündigung von Butterfly, dass das Unternehmen im zweiten Quartal den höchsten Quartalsumsatz erzielt hat, mit einem Ergebnis von 21,5 Millionen Dollar, was einem 16% Wachstum im Vergleich zum Vorjahr entspricht. Dieser Erfolg unterstreicht die wachsende Nachfrage nach Butterflies innovativer Ultraschalltechnologie und die Effektivität seiner Strategie.
- Appointment of Steve Cashman as Chief Business Officer, bringing extensive healthcare technology expertise
- Record-breaking Q2 revenue of $21.5 million, representing 16% year-over-year growth
- Successful launch of third-generation Butterfly iQ3 product
- None.
Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum
Steve Cashman, Chief Business Officer, Butterfly Network (Photo: Business Wire)
Steve Cashman has built a reputation in the healthcare industry for his extensive health technology expertise, commercial leadership and strategic foresight. Most recently, he served as President and Chief Executive Officer of Caption Health, where he led the company through the development and commercialization of the industry’s first AI-powered ultrasound platform, culminating in its acquisition by GE Healthcare. Prior to that, Cashman was Chief Commercial Officer at InTouch Health through its acquisition by Teladoc, where he significantly expanded the company’s global footprint and drove key initiatives across product, marketing, and customer service.
Earlier in his career, he served as Chief Executive Officer of HealthSpot, a telehealth company acquired by Rite Aid, among other leadership and board positions. He is engaged in the startup community as a seasoned entrepreneur and angel investor, and is currently on the board of Sovato, TympaHealth Technologies, Vista.ai, and PatientGenie.
“The addition of Steve Cashman to our management team is another key marker of an outstanding 2024 for Butterfly,” said Joseph DeVivo, President, Chief Executive Officer, and Board Chairman of Butterfly Network. “Steve joins us with profound knowledge of the ultrasound market, deep connection in the artificial intelligence space, and a thorough understanding of Butterfly’s technology. I’ve witnessed Steve’s strategic acumen and capacity for driving growth and innovation firsthand, and I’m beyond confident that he will be a major asset to us as we continue to enhance our commercial activities and deliver on our product roadmap.”
Cashman commented, “Joining Butterfly Network at this moment is incredibly exciting. I’m a firm believer in technology’s potential to enhance patient care and expand access to healthcare. Butterfly has what it takes to drive the industry forward – it’s the right technology with the right approach. I’m eager to bring a fresh values-driven mindset and customer-first approach to the company. Together with the Butterfly team, I look forward to driving meaningful progress in the field and in our performance. The opportunity to make imaging happen earlier in the care journey has the potential to improve quality and make healthcare more equitable.”
Cashman’s appointment comes on the heels of Butterfly’s announcement of a record-breaking second quarter. The company reported its highest quarterly revenue in history, with second-quarter revenue reaching
For more information on Butterfly Network, visit www.butterflynetwork.com.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law to launch its second-generation Butterfly iQ+ in 2020 and third-generation iQ3 in 2024—each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including but not limited to parts of
View source version on businesswire.com: https://www.businesswire.com/news/home/20240903622202/en/
Butterfly Media:
Liz Learned
Head of Corporate Communications
media@butterflynetwork.com
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officer
investors@butterflynetwork.com
Source: Butterfly Network, Inc.
FAQ
Who is Steve Cashman and what is his new role at Butterfly Network (BFLY)?
What was Butterfly Network's (BFLY) Q2 2024 revenue?
What is the Butterfly iQ3 mentioned in relation to Butterfly Network (BFLY)?
How does Steve Cashman's appointment impact Butterfly Network's (BFLY) business strategy?
